Cleven Injection 8000 Anti-Xa IU/0.8 ml contains Enoxaparin Sodium, a low molecular weight heparin (LMWH) widely used as an anticoagulant for the prevention and treatment of thromboembolic disorders. Enoxaparin works by inhibiting clot formation, thereby reducing the risk of potentially life-threatening complications such as deep vein thrombosis and pulmonary embolism.

Cleven Injection is commonly prescribed in hospital and clinical settings for patients at risk of blood clots due to surgery, prolonged immobilization, or underlying medical conditions. Its predictable anticoagulant response and convenient dosing make it a trusted choice for both preventive and therapeutic anticoagulation.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Composition and Mechanism of Action

Enoxaparin Sodium 8000 Anti-Xa IU/0.8 ml

Enoxaparin Sodium enhances the inhibitory effect of antithrombin III, primarily against factor Xa and to a lesser extent against thrombin (factor IIa). Its key actions include:

• Prevention of fibrin clot formation

• Reduction of blood coagulation without significantly affecting platelet function

• Predictable anticoagulant activity with a lower risk of bleeding compared to unfractionated heparin

By selectively inhibiting clotting factors, Cleven Injection helps maintain normal blood flow and prevents clot extension.

Indications

Cleven Injection 8000 Anti-Xa IU/0.8 ml is indicated for:

• Prevention of deep vein thrombosis in patients undergoing surgery

• Prevention of thromboembolic complications in immobilized or critically ill patients

• Treatment of deep vein thrombosis with or without pulmonary embolism

• Management of unstable angina and non-Q-wave myocardial infarction

• Anticoagulation during hemodialysis

Use should always be based on clinical evaluation and medical advice.

Benefits of Cleven Injection

• Effective anticoagulation with predictable response

• Lower risk of heparin-induced thrombocytopenia

• Reduced need for routine laboratory monitoring

• Convenient subcutaneous administration

• Suitable for both preventive and therapeutic use

Dosage and Administration

• Dosage and duration depend on the indication, body weight, and patient condition

• Administered by subcutaneous injection

• Should be given by trained healthcare professionals or as instructed by a physician

• Injection sites should be rotated to minimize local irritation

Do not administer intramuscularly.

Safety Information and Precautions

Possible Side Effects

Some patients may experience:

• Bleeding or bruising at the injection site

• Anemia

• Thrombocytopenia

• Elevated liver enzymes

• Local pain or redness

Any signs of unusual bleeding should be reported immediately.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Precautions

• Use with caution in patients with bleeding disorders

• Regular monitoring may be required in patients with renal impairment

• Not recommended in patients with active major bleeding

• Inform your doctor about all medications, especially other anticoagulants or antiplatelet drugs

• Use during pregnancy or breastfeeding only if clearly indicated

Storage Conditions

• Store below the recommended temperature as stated on the label

• Protect from light

• Do not freeze

• Keep out of reach of children

Conclusion

Cleven Injection 8000 Anti-Xa IU/0.8 ml (Enoxaparin Sodium) is a clinically proven anticoagulant used for the prevention and treatment of thromboembolic disorders. With its reliable efficacy, safety profile, and ease of administration, it plays a vital role in modern anticoagulation therapy under proper medical supervision.